Literature DB >> 14666999

Effect of feed restriction on Hershberger and pubertal male assay endpoints.

M Sue Marty1, Keith A Johnson, Edward W Carney.   

Abstract

BACKGROUND: The Hershberger and male pubertal onset assays have been identified as possible Tier I screening tests to detect endocrine-active compounds (EACs). Both tests rely on changes in reproductive and/or accessory sex gland (ASG) weights in young animals. Because chemical treatment may affect growth rate, the relationship between body weight and reproductive/ASG weights was examined using feed restriction (FR) to produce a targeted 10% decrease in body weight.
METHODS: In the male pubertal onset assay, 23-day-old rats (12/group) were given ad lib feed or FR until euthanized at 45, 49, 52, 56, or 59 days of age. Despite a 10% body weight differential, pubertal onset was not significantly delayed and testes weights were conserved. Absolute prostate, ventral prostate, seminal vesicle, epididymides, and liver weights were decreased by FR. Relative weights for the prostate, ventral prostate, and seminal vesicles were similar to controls, but relative epididymides and liver weights still exhibited FR-mediated changes. In the Hershberger assay, male rats (12/group) castrated at 36 days of age were given ad lib feed or FR in the presence or absence of testosterone propionate (T) from 46-55, 50-59, or 56-65 days of age. At 56, 60, and 66 days of age, rats were euthanized. In untreated animals, FR did not alter absolute ventral prostate, seminal vesicles, or Cowper's gland weights; however, absolute and relative weights of the levator anibulbocavernosus muscles (LABC) were affected. In T-treated animals, absolute organ weights (the ventral prostate, seminal vesicles, LABC, and glans penis) were relatively insensitive to FR. The weight of the Cowper's gland was affected only at 66 days of age.
RESULTS: These data show that reproductive and ASG organ weight endpoints in the Hershberger and male pubertal onset assays can be influenced by FR levels that produce a 10% change in terminal body weight.
CONCLUSIONS: The establishment of objective criteria for a positive or negative result is problematic due to the confounding effects of body weight on some endpoints. Furthermore, a 10% decrease in body weight seems to be excessive as a requirement for high-dose toxicity in these assays due to possible indictment of agents that are not EACs, as well as potential masking of EAC effects coincident with body weight changes. Minimally, caution must be used in interpreting assay results in the presence of a 10% body weight change, recognizing the possible confounding effects of this degree of growth suppression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14666999     DOI: 10.1002/bdrb.10028

Source DB:  PubMed          Journal:  Birth Defects Res B Dev Reprod Toxicol        ISSN: 1542-9733


  5 in total

1.  Scientific and Regulatory Policy Committee Points to Consider Review: Inclusion of Reproductive and Pathology End Points for Assessment of Reproductive and Developmental Toxicity in Pharmaceutical Drug Development.

Authors:  Wendy G Halpern; Mehrdad Ameri; Christopher J Bowman; Michael R Elwell; Michael L Mirsky; Julian Oliver; Karen S Regan; Amera K Remick; Vicki L Sutherland; Kary E Thompson; Claudine Tremblay; Midori Yoshida; Lindsay Tomlinson
Journal:  Toxicol Pathol       Date:  2016-05-27       Impact factor: 1.902

2.  Use of the three-spined stickleback (Gasterosteus aculeatus) as a sensitive in vivo test for detection of environmental antiandrogens.

Authors:  Ioanna Katsiadaki; Steven Morris; Christopher Squires; Mark Richard Hurst; Jonathan David James; Alexander Pickering Scott
Journal:  Environ Health Perspect       Date:  2006-04       Impact factor: 9.031

3.  An F1-extended one-generation reproductive toxicity study in Crl:CD(SD) rats with 2,4-dichlorophenoxyacetic acid.

Authors:  Mary Sue Marty; Barbara H Neal; Carol L Zablotny; Barry L Yano; Amanda K Andrus; Michael R Woolhiser; Darrell R Boverhof; Shakil A Saghir; Adam W Perala; Julie K Passage; Marie A Lawson; James S Bus; James C Lamb; Larry Hammond
Journal:  Toxicol Sci       Date:  2013-09-26       Impact factor: 4.849

4.  Key lessons from performance of the U.S. EPA Endocrine Disruptor Screening Program (EDSP) Tier 1 male and female pubertal assays.

Authors:  Donald G Stump; John C O'Connor; Joseph M Lewis; M Sue Marty
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2014-02-07

5.  Key learnings from the Endocrine Disruptor Screening Program (EDSP) Tier 1 rodent uterotrophic and Hershberger assays.

Authors:  M Sue Marty; John C O'Connor
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2014-02-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.